Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma

SIMPLE SUMMARY: Thymic carcinoma is a rare cancer, and its biology remains largely unknown. Although complete surgical resection is a standard treatment for thymic carcinoma, systemic chemotherapy is frequently administered in metastatic or recurrent cases. Given the rarity, therapeutic agents are o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitadai, Rui, Okuma, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533972/
https://www.ncbi.nlm.nih.gov/pubmed/34680386
http://dx.doi.org/10.3390/cancers13205239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533972/
https://www.ncbi.nlm.nih.gov/pubmed/34680386
http://dx.doi.org/10.3390/cancers13205239

Ejemplares similares